Cargando…

Hereditary hemorrhagic telangiectasia with liver cirrhosis: a case report

BACKGROUND: Hereditary hemorrhagic telangiectasia is an autosomal dominant hereditary hemorrhagic disease. Its main feature is an abnormal structure of the blood vessel wall. Cirrhosis of the liver is a common chronic progressive disease with one or more causes in which diffuse liver damage occurs a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Linxia, Xu, Feng, Wang, Qizhi, Ke, Xiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422673/
https://www.ncbi.nlm.nih.gov/pubmed/34488642
http://dx.doi.org/10.1186/s12876-021-01913-3
_version_ 1783749322984128512
author Xu, Linxia
Xu, Feng
Wang, Qizhi
Ke, Xiquan
author_facet Xu, Linxia
Xu, Feng
Wang, Qizhi
Ke, Xiquan
author_sort Xu, Linxia
collection PubMed
description BACKGROUND: Hereditary hemorrhagic telangiectasia is an autosomal dominant hereditary hemorrhagic disease. Its main feature is an abnormal structure of the blood vessel wall. Cirrhosis of the liver is a common chronic progressive disease with one or more causes in which diffuse liver damage occurs after long-term or repeated injury. Liver cirrhosis can cause dilation of gastrointestinal capillaries. Many patients with hereditary hemorrhagic telangiectasia accompanied by gastrointestinal vascular malformations and liver cirrhosis may be diagnosed only with liver cirrhosis if the clinician does not pay attention to physical examination findings and family history. Moreover, general treatment measures, such as blood transfusion, iron supplementation, and application of hemostatic drugs, are less effective for bleeding in patients with hereditary hemorrhagic telangiectasia than in those with liver cirrhosis alone. CASE PRESENTATION: Here, we report the rare case of a 75-year-old Chinese man who was admitted to the hospital with repeated melena and epistaxis. He was diagnosed with unexplained liver cirrhosis, which was later confirmed as hereditary hemorrhagic telangiectasia. Subsequently, we implemented the treatment intervention of oral thalidomide combined with gastrointestinal argon plasma coagulation. A follow-up of more than 8 months showed that the treatment effect was excellent. CONCLUSIONS: If patients with liver cirrhosis and gastrointestinal vascular malformations also have a family history of epistaxis, special attention should be paid to targeted physical examination results, and the possibility of hereditary hemorrhagic telangiectasia should be considered. Moreover, for patients with hereditary hemorrhagic telangiectasia and both gastrointestinal bleeding caused by gastrointestinal capillaries and repeated epistaxis, when other general treatment measures are ineffective, thalidomide combined with gastrointestinal argon plasma coagulation may be an effective intervention.
format Online
Article
Text
id pubmed-8422673
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84226732021-09-09 Hereditary hemorrhagic telangiectasia with liver cirrhosis: a case report Xu, Linxia Xu, Feng Wang, Qizhi Ke, Xiquan BMC Gastroenterol Case Report BACKGROUND: Hereditary hemorrhagic telangiectasia is an autosomal dominant hereditary hemorrhagic disease. Its main feature is an abnormal structure of the blood vessel wall. Cirrhosis of the liver is a common chronic progressive disease with one or more causes in which diffuse liver damage occurs after long-term or repeated injury. Liver cirrhosis can cause dilation of gastrointestinal capillaries. Many patients with hereditary hemorrhagic telangiectasia accompanied by gastrointestinal vascular malformations and liver cirrhosis may be diagnosed only with liver cirrhosis if the clinician does not pay attention to physical examination findings and family history. Moreover, general treatment measures, such as blood transfusion, iron supplementation, and application of hemostatic drugs, are less effective for bleeding in patients with hereditary hemorrhagic telangiectasia than in those with liver cirrhosis alone. CASE PRESENTATION: Here, we report the rare case of a 75-year-old Chinese man who was admitted to the hospital with repeated melena and epistaxis. He was diagnosed with unexplained liver cirrhosis, which was later confirmed as hereditary hemorrhagic telangiectasia. Subsequently, we implemented the treatment intervention of oral thalidomide combined with gastrointestinal argon plasma coagulation. A follow-up of more than 8 months showed that the treatment effect was excellent. CONCLUSIONS: If patients with liver cirrhosis and gastrointestinal vascular malformations also have a family history of epistaxis, special attention should be paid to targeted physical examination results, and the possibility of hereditary hemorrhagic telangiectasia should be considered. Moreover, for patients with hereditary hemorrhagic telangiectasia and both gastrointestinal bleeding caused by gastrointestinal capillaries and repeated epistaxis, when other general treatment measures are ineffective, thalidomide combined with gastrointestinal argon plasma coagulation may be an effective intervention. BioMed Central 2021-09-06 /pmc/articles/PMC8422673/ /pubmed/34488642 http://dx.doi.org/10.1186/s12876-021-01913-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Xu, Linxia
Xu, Feng
Wang, Qizhi
Ke, Xiquan
Hereditary hemorrhagic telangiectasia with liver cirrhosis: a case report
title Hereditary hemorrhagic telangiectasia with liver cirrhosis: a case report
title_full Hereditary hemorrhagic telangiectasia with liver cirrhosis: a case report
title_fullStr Hereditary hemorrhagic telangiectasia with liver cirrhosis: a case report
title_full_unstemmed Hereditary hemorrhagic telangiectasia with liver cirrhosis: a case report
title_short Hereditary hemorrhagic telangiectasia with liver cirrhosis: a case report
title_sort hereditary hemorrhagic telangiectasia with liver cirrhosis: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422673/
https://www.ncbi.nlm.nih.gov/pubmed/34488642
http://dx.doi.org/10.1186/s12876-021-01913-3
work_keys_str_mv AT xulinxia hereditaryhemorrhagictelangiectasiawithlivercirrhosisacasereport
AT xufeng hereditaryhemorrhagictelangiectasiawithlivercirrhosisacasereport
AT wangqizhi hereditaryhemorrhagictelangiectasiawithlivercirrhosisacasereport
AT kexiquan hereditaryhemorrhagictelangiectasiawithlivercirrhosisacasereport